New Deal

Advanced Medical Solutions Grp PLC
7 January 2002


For Immediate Release:                            07.00, Monday, 7 January 2002

                     Advanced Medical Solutions Group plc

                           ('AMS' or the 'Company')

Agrees Silver Fibre Technology Deal with Noble Fiber Technologies Inc.('Noble')

Winsford, Cheshire, UK: AMS, the medical device company, today announces that
it has licensed novel 'X-STATIC(R)' silver fibre technology from Noble. The
agreement enables AMS to use X-STATIC(R) silver fibres in its alginate based
woundcare dressings and also grants AMS exclusive world-wide rights to seek
marketing partners for these products.

Silver is widely recognised as a safe and effective broad spectrum
anti-microbial agent for infection control.  The X-STATIC(R) silver fibre
technology utilises a layer of pure silver, bonded to the surface of a textile
fibre, which enables it to be incorporated into an alginate dressing and
allows a controlled and sustained release of silver into the wound. During
2001, AMS commenced development of products fabricated from these silver and
alginate fibres.  The Company will now progress discussions with international
marketing partners to secure licensing and supply agreements for these new,
anti-microbial wound dressings as they are progressed through trials.

AMS supplies a range of advanced products to leading woundcare companies on a
global basis and the licensing-in of the X-STATIC(R) technology continues the
Company's strategy of moving towards more technically advanced, higher value
products.

Commenting on the announcement, Bill McNally, President & CEO of Noble  Fiber
Technologies said:  'We see the medical arena, and woundcare in particular, as
a very exciting growth area where the established anti-microbial, anti-odour
and therapeutic performance of our X-STATIC(R) technology can offer real
benefits.  We are very excited at the prospects offered by entering into this
relationship with AMS due to its complementary technology, excellent partner
base and new product development pipeline.  In this respect, we also see
future possibilities to leverage this relationship into other material areas
and other medical products in the future.'

Chief Executive Officer of AMS, Don Evans, commented:  'To have secured the
license for this leading silver technology is extremely exciting for AMS and
puts us firmly at the forefront of the higher value end of the advanced
woundcare market.  The agreement will help us to continue to strengthen our
position as a premium supplier of advanced woundcare products and we look
forward to securing marketing partner agreements and to progressing through
the regulatory pathways necessary to launch these products, initially into the
hospital markets.'

                                   - ENDS -

For further information, please contact:

Advanced Medical Solutions Group plc              Tel: [phone]
Don Evans, Chief Executive
Graeme Brookes, Sales & Marketing Director
www.admedsol.com

Buchanan Communications                           Tel: [phone]
Nicola How / Fergus Mellon

Notes to Editors:

Advanced Medical Solutions is a leading global company in the development and
manufacture of products for the £1billion global advanced wound care market.

Founded in 1991 and floated on the Full List of the London Stock Exchange in
1996, Advanced Medical Solutions is focused on the design, development and
manufacture of innovative and technologically advanced products for wound care
and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson,
Molnlycke Healthcare, Coloplast and Smith + Nephew / Beiersdorf.

In addition to the Professional and Consumer Woundcare divisions, AMS has
established a Research & Technology Division.  This was set up in 1999 to ring
fence technical expertise to develop technology platforms for the future. The
key focus of Research & Technology is to develop new material and device
technologies for commercialisation.

Noble Fiber Technologies:

Noble Fiber Technologies is a world leader in silver technology with core
businesses in the consumer retail sector and in healthcare. 'X-STATIC(R)'
silver fibres feature a layer of pure silver permanently bonded to a textile
fibre, which offers safe, sustained anti-microbial performance.